TITLE:
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70

CONDITION:
Open-Angle Glaucoma

INTERVENTION:
Alcon Investigational Agent

SUMMARY:

      To compare intraocular pressure lowering effectiveness of a combination drug vs. two
      individual drugs dosed alone.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Adult subjects of either sex and any race with open-angle glaucoma or ocular hypertension;
        visual acuity of 20/80 to 20/400 or better (Snellen equivalent) or logMAR visual acuity
        not worse than 0.6. Clinically relevant ophthalmic or systemic conditions may be excluded.
      
